Therapeutic efficacy of macrolides in management of patients with mild COVID-19

Evidence on the efficacy of adding macrolides (azithromycin or clarithromycin) to the treatment regimen for COVID-19 is limited. We testify whether adding azithromycin or clarithromycin to a standard of care regimen was superior to standard of supportive care alone in patients with mild COVID-19.Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashad, Alaa, Nafady, Asmaa, Hassan, Mohammed H., Mansour, Haggagy, Taya, Usama, Bazeed, Shamardan Ezzeldin S., Aref, Zaki F., Sayed, Mennatallah Ali Abdelrhman, Nafady-Hego, Hanaa, Abdelmaksoud, Aida A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357809/
https://www.ncbi.nlm.nih.gov/pubmed/34381155
http://dx.doi.org/10.1038/s41598-021-95900-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357809/
https://www.ncbi.nlm.nih.gov/pubmed/34381155
http://dx.doi.org/10.1038/s41598-021-95900-z

Ejemplares similares